Vanda Pharmaceuticals
VNDA
#7485
Rank
ยฃ0.30 B
Marketcap
ยฃ5.22
Share price
4.15%
Change (1 day)
40.20%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -ยฃ91.26 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2024 the company made an earning of -ยฃ30.2 Million a decrease over its 2023 earnings that were of -ยฃ10.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ91.26 Million202.27%
2024 -ยฃ30.2 Million191.43%
2023 -ยฃ10.36 Million-320.45%
2022 ยฃ4.69 M-84.99%
2021 ยฃ31.3 M54.8%
2020 ยฃ20.22 M19.42%
2019 ยฃ16.93 M4.93%
2018 ยฃ16.14 M-228.6%
2017 -ยฃ12.56 Million-8.98%
2016 -ยฃ13.79 Million-53.79%
2015 -ยฃ29.84 Million-30.18%
2014 -ยฃ42.74 Million173.08%
2013 -ยฃ15.65 Million-25.33%
2012 -ยฃ20.96 Million163.61%
2011 -ยฃ7.95 Million-221.15%
2010 ยฃ6.56 M-124.53%
2009 -ยฃ26.76 Million-29.44%
2008 -ยฃ37.92 Million-36.2%
2007 -ยฃ59.43 Million21.81%
2006 -ยฃ48.79 Million170.55%
2005 -ยฃ18.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ12.19 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ16.70 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.05 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.96 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.80 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.09 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.14 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA